The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

about

Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.Two-incision laparoscopic appendectomy for a severe hemophilia A child patient with coagulation factor VII deficiency: Case report and review of literature.

P2860

Q37845931-B04EB573-443B-4394-AD77-789BE18491A5 Q41922244-57264181-8703-48BB-86B7-32E7B8F425AB

P2860

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

Item

http://www.wikidata.org/entity/Q45869094

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

@en

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

@nl

type

Item

label

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

@en

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

@nl

prefLabel

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

@en

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

@nl

P1476

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

@en

P2093

Dusica Simic

http://www.w3.org/2001/XMLSchema#string

Irina Milojevic

http://www.w3.org/2001/XMLSchema#string

P2860

On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation.

Pharmacokinetics of recombinant activated factor VII (rFVIIa).

Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.

The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.

Orthopaedic surgery in haemophilic patients with inhibitors: an overview.

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.

Advances in care of children with hemophilia.

Current concepts of hemostasis: implications for therapy.

A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision.

Recombinant activated factor VII.

P304

789-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1460-9592.2007.02220.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17596224

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia A

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

about

P2860

P2860

The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921